Search clinical trials for: (SOF, DCV, and RBV)

Total 147404 results

Bristol-Myers Squibb

Completed

A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

Hepatitis C

United States, Canada
Beni-Suef University

Completed

Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4

Chronic Hepatitis C Virus Infection
University Hospital, Toulouse

Withdrawn

Rehabilitation Exercise With MObile Technology and Education After Acute Coronary Syndrome (REMOTE-ACS)

Acute Coronary Syndrome

France
Assistance Publique - Hôpitaux de Paris
Gilead Sciences

Terminated

HCV, HBV, HIV Testing During Consultation With Anesthesiologist (SAHARA)

Hiv | HBV | HCV

France
Timothy Morgan, MD
Bristol-Myers Squibb; National Cancer Institute (NCI); VA Long Beach Healthcare...

Completed

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus (RHACE 1)

Hepatitis C

United States
Tarek I. Hassanein, M.D., FACP, FAG, AGAF

Completed

Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics

Hepatitis C | Cirrhosis

United States
Aivita Biomedical, Inc.

Withdrawn

Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults

COVID-19
Seoul National University Bundang Hospital

Unknown

Pressure-controlled Versus Volume-controlled Ventilation During Protective One Lung Ventilation

Arterial Oxygenation During Protective One Lung Ventilation

Korea, Republic of
Hannover Medical School
AbbVie

Terminated

MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV

Hepatitis C, Chronic

Germany
Nantes University Hospital

Completed

Study on the Prevalence of Hepatitis C In a psychiatRic Population (SaPHIR)

Hepatitis C

France
CHU de Reims

Completed

Interest of Routine Screening for Hepatitis B and C in Patients Receiving Chemotherapy for Solid Tumors (HepScreen)

Solid Tumor

France
Hasselt University
University Ghent

Completed

HBV/HCV/HIV in Belgian Prisons

HIV Infections | Hepatitis B | Hepatitis C

Belgium
Tibotec Pharmaceuticals, Ireland

Completed

TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions

HIV Infections
Humanity and Health Research Centre
Beijing 302 Hospital

Completed

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients

Chronic Hepatitis C Infection

China
East Slovak Institute for Cardiovascular Diseases

Completed

Expiratory Time Constant in Mechanically Ventilated Patients

Comparing Six Different Methods to Obtain Expiratory Time Constant

Slovakia
Humanity & Health Medical Group Limited

Withdrawn

Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection

HCV Infection

Hong Kong
Tongji Hospital
Kousai Bio Co., Ltd.

Enrolling by invitation

KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial

EBV-associated Haematologic Neoplasms

China
National Taiwan University Hospital
AbbVie

Completed

PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis (PIVOTAL)

Hepatitis Viruses

Taiwan
Kirby Institute
Bristol-Myers Squibb

Withdrawn

Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism (HEPCOG-II)

Hepatitis C, Chronic

Australia
Bristol-Myers Squibb

Terminated

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV (DIMENSION)

Chronic Hepatitis C Infection

France, Germany, United States, Spain, Canada, Argentina, Mexico, Belgium, Italy, Russian Federation, United Kingdom, Poland
Derince Training and Research Hospital

Completed

Evaluation of Effect of Different Ventilator Mods on Atelectasis in Patients Undergoing Laparoscopic Surgery (PCV-VG)

Atelectasis | Atelectases, Postoperative Pulmonary

Turkey
National University Hospital, Singapore

Unknown

Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Cancer

Singapore
Valme University Hospital
Hospital General Universitario Elche; Hospital del SAS de Jerez; Clinica Universidad... and other collaborators

Completed

Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions (FPSMON201401)

Chronic Hepatitis C Infection

Spain
Gilead Sciences

Completed

Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION) (FUSION)

Chronic Hepatitis C

United States, Canada, New Zealand, Puerto Rico
California Department of Public Health

Not yet recruiting

Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG®

Botulism

United States
Beijing Kawin Technology Share-Holding Co., Ltd.

Completed

A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C

Chronic Hepatitis C

China
Beni-Suef University

Completed

ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants

Chronic Hepatitis C Virus Infection

Egypt
California Department of Public Health

Completed

Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG®

Botulism

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults

RECOMBINANT BOTULINUM VACCINE A/B

United States
Gilead Sciences

Completed

Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection

Hepatitis C

Spain, Netherlands, Austria, France, United Kingdom, Italy, Estonia, Germany, Poland, Sweden
Humanity and Health Research Centre
University of Maryland; Emory University; Beijing 302 Hospital

Withdrawn

Triple Combination DAAs for Treating HCV GT1b Subjects

Chronic Hepatitis C Infection

Hong Kong
Gilead Sciences

Completed

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon (POSITRON)

Chronic Hepatitis C

United States, Canada, New Zealand, Puerto Rico, Australia
Beni-Suef University

Completed

Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4 (HCV)

Hepatitis C Virus Infection
National Taiwan University Hospital
National Science Council, Taiwan; Department of Health, Executive Yuan, R.O...

Completed

Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR

Chronic Hepatitis C

Taiwan
California Department of Public Health

Completed

Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid

Botulism

United States
Beijing Kawin Technology Share-Holding Co., Ltd.

Completed

Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C

Chronic Hepatitis c

China
Centre Hospitalier Universitaire Vaudois

Not yet recruiting

PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma (CHUV-OVACURE)

Ovarian Carcinoma
DynPort Vaccine Company LLC, A GDIT Company

Completed

Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

Botulism Vaccine

United States
Bristol-Myers Squibb

Completed

A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1 (UNITY 4)

Hepatitis C Virus

Korea, Republic of, Taiwan, Russian Federation
MedImmune LLC

Completed

A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults

Respiratory Syncytial Virus (RSV)

United States
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection

HCV Infection

France
ViiV Healthcare
GlaxoSmithKline

Completed

Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects

Infection, Human Immunodeficiency Virus

United States
International Centre for Diarrhoeal Disease Research...
Centers for Disease Control and Prevention

Not yet recruiting

Co-administration Study of OCV, TCV and MR

Measles | Rubella | Cholera | Typhoid
Ascletis Pharmaceuticals Co., Ltd.

Completed

Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China

Healthy
Beni-Suef University

Completed

Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients

Chronic Hepatitis C Virus Infection

Egypt
Heidelberg University

Terminated

Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency

Hereditary Emphysema (Alpha 1-antitrypsin Deficiency)

Germany
Gary Archer Ph.D.
Bristol-Myers Squibb; Duke Cancer Institute

Completed

Nivolumab With DC Vaccines for Recurrent Brain Tumors (AVERT)

Glioblastoma | Astrocytoma | Malignant Glioma

United States
California State University, Long Beach
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Science Aspects of Rapid Test Acceptance (BSARTA)

Hepatitis B | Hepatitis C | HIV | Syphilis

United States
The HIV Netherlands Australia Thailand Research...
Merck Sharp & Dohme LLC; Chulalongkorn University

Unknown

Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV

Compensated Cirrhosis

Thailand
Beni-Suef University

Completed

Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4

Hepatitis C Virus Infection

3

Subscribe